Anti-BLyS/APRIL Antibody (Telitacicept)
Catalog No.
F2103
Anti-BLyS/APRIL Antibody (Telitacicept)
Featured Products
Telitacicept is a bispecific fusion protein developed by a Chinese biopharmaceutical company, mainly composed of TACI (transmembrane activator and calmodulin interacting molecule) and IgG Fc fragment. Its mechanism is to inhibit the excessive activation of B cells by binding BLyS (B cell activating factor) and APRIL (proliferation inducing ligand), so as to treat autoimmune diseases such as systemic lupus erythematosus.
Dry ice
2136630-26-5
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
RC18
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
BLyS/APRIL
Please avoid freeze-thaw cycles.